Prostate cancer is the second most common cancer in men. In fact, about 1 in 7 men will be diagnosed with this disease during his lifetime. However, most cases are detected in an early stage and are low-risk, posing little or no threat to the patient. Based on the value of 3D imaging, mapping and precisely correlated data, KOELIS, The Prostate Care Company, provides a more precise, targeted approach against random, non-personalized baselines. This individualized method allows the clinician to effectively treat tumors while preserving patient’s quality of life and reducing costs. Easily integrated in the healthcare system and in the clinical routine, KOELIS’ integrated technology boasts streamlined workflow and allows for multi-disciplinary decision making, increasing productivity and improving the patient’s experience.
KOELIS’ cutting-edge comprehensive solution guarantees integrated attention by offering patient-tailored, evidence-based and cost-conscious care at any step of prostate cancer management; from screening and diagnosis to patient selection, treatment and follow-up.